Faculty publications

Austin Armstrong

1. Kansas Needs Psychiatric Subspecialists. Armstrong AG, Mayorga AK, Brown RM.Kans J Med. 2022 Jun 20;15(2):222-225. doi: 10.17161/kjm.vol15.16506. eCollection 2022.PMID: 35762000 Free PMC article. No abstract available.

2. Metronidazole-Induced Leukoencephalopathy Presenting as Catatonia. Armstrong AG, Kalia R.Prim Care Companion CNS Disord. 2021 Sep 23;23(5):20l02841. doi: 10.4088/PCC.20l02841.PMID: 34559479 Free article. No abstract available.

3. Thoughts on the Value of Case Series in the Literature: An Example Using the Article on Lurasidone Augmentation of Clozapine in Refractory Schizophrenia. Armstrong AG, Preskorn SH.J Clin Psychopharmacol. 2023 Mar-Apr 01;43(2):87-88. doi: 10.1097/JCP.0000000000001676.PMID: 36821468 No abstract available.

4. What do female medical students know about planned oocyte cryopreservation and what are their personal attitudes? Armstrong AG, Woods M, Keomany J, Grainger D, Shah S, Pavone M.J Assist Reprod Genet. 2023 Jun;40(6):1305-1311. doi: 10.1007/s10815-023-02845-5. Epub 2023 Jun 22.PMID: 37347348 Free PMC article.

5. Lamotrigine Drug Interactions: Ignorance is not Bliss. Armstrong AG, Kalia R, Troutman M.Kans J Med. 2022 Mar 15;15(1):109-111. doi: 10.17161/kjm.vol15.15798. eCollection 2022.PMID: 35345572 Free PMC article. No abstract available.

6. Can the Publication of Case Series or Case Reports Lead to a Change in Clinical Practice? Preskorn SH, Armstrong AG.J Psychiatr Pract. 2023 Mar 1;29(2):137-141. doi: 10.1097/PRA.0000000000000701.PMID: 36928200

7. Publisher Correction: Compression and amplification algorithms in hearing aids impair the selectivity of neural responses to speech. Armstrong AG, Lam CC, Sabesan S, Lesica NA.Nat Biomed Eng. 2022 Jun;6(6):790. doi: 10.1038/s41551-021-00843-5.PMID: 34987172 No abstract available.

8. What Can You Learn About Psychiatry Programs from Their Website? A Content Evaluation for Potential Applicants. Armstrong AG, Fraser KW, Nix SN, Zackula R, Brown R, Macaluso M.Acad Psychiatry. 2024 Feb;48(1):29-35. doi: 10.1007/s40596-023-01916-0. Epub 2023 Dec 8.PMID: 38066297

Matthew Byerly

1. A scoping review of the reporting quality of reviews of commercially and publicly available mobile health apps. Gasteiger N, Norman G, Grainger R, van der Veer SN, McGarrigle L, Jones D, Eost-Telling C, Vercell A, Ford CR, Ali SM, Law K, Zhao Q, Byerly M, Shi C, Davies A, Hall A, Dowding D.JAMIA Open. 2025 Jan 13;8(1):ooae159. doi: 10.1093/jamiaopen/ooae159. eCollection 2025 Feb.PMID: 39810923 Free PMC article. Review.

2. Reporting quality of published reviews of commercial and publicly available mobile health apps (mHealth app reviews): a scoping review protocol. Gasteiger N, Norman G, Grainger R, Eost-Telling C, Jones D, Ali SM, van der Veer SN, Ford CR, Hall A, Law K, Byerly M, Davies A, Paripoorani D, Shi C, Dowding D.BMJ Open. 2024 Jul 4;14(7):e083364. doi: 10.1136/bmjopen-2023-083364.PMID: 38964792 Free PMC article.

3. Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population. Anderson JR, Killian M, Fuller A, Hughes JL, Byerly M, Lindow J, John Rush A, Trivedi MH.Child Psychiatry Hum Dev. 2022 Jun;53(3):546-553. doi: 10.1007/s10578-021-01148-z. Epub 2021 Mar 13.PMID: 33713250

4. A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia. Nakonezny PA, Lindow JC, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Byerly MJ.Schizophr Res. 2020 Jun;220:92-97. doi: 10.1016/j.schres.2020.03.053. Epub 2020 Apr 5.PMID: 32269005 Free PMC article.

5. The Youth Aware of Mental Health Intervention: Impact on Help Seeking, Mental Health Knowledge, and Stigma in U.S. Adolescents. Lindow JC, Hughes JL, South C, Minhajuddin A, Gutierrez L, Bannister E, Trivedi MH, Byerly MJ. J Adolesc Health. 2020 Jul;67(1):101-107. doi: 10.1016/j.jadohealth.2020.01.006. Epub 2020 Feb 27.PMID: 32115325 Free PMC article.

Susanna Ciccolari Micaldi

1. Expert Team in Your Back Pocket: Recommendations From a Pediatric Mental Health Access Program. Harris K, Aguila Gonzalez AI, Vuong NX, Singh N, Brown R, Ciccolari Micaldi S.Clin Pediatr (Phila). 2023 Oct;62(10):1217-1228. doi: 10.1177/00099228231154122. Epub 2023 Mar 7.PMID: 36880385

2. Understanding Pediatric Mental Health in Primary Care: Needs in a Rural State. Harris K, Aguila Gonzalez A, Vuong N, Brown R, Ciccolari Micaldi S.Clin Pediatr (Phila). 2023 Jun;62(5):441-448. doi: 10.1177/00099228221136121. Epub 2022 Nov 9.PMID: 36352499

3. Do Two Rights Make a Wrong? A Case Report on Reversible Neurotoxicity Induced by Coadministration of Clozapine and Lithium. Masolak DD, Micaldi SC.Kans J Med. 2022 Nov 28;15(3):425-427. doi: 10.17161/kjm.vol15.18501. eCollection 2022.PMID: 36467443 Free PMC article. No abstract available.

4. Steroid-Induced Mania in a 12-Year-Old Adolescent: A Case Report. Le V, Abbasy MS, Micaldi SC.Kans J Med. 2025 Jun 16;18(3):54-58. doi: 10.17161/kjm.vol18.23221. eCollection 2025 May-Jun.PMID: 40547495 Free PMC article. No abstract available.

5. Is it Worsening ADHD or Graves' Disease? A Case Report of Undiagnosed Graves' Disease in a Patient with ADHD. Lin HH, Morelli N, Micaldi SC.Kans J Med. 2024 Mar 15;17(1):18-19. doi: 10.17161/kjm.vol17.21368. eCollection 2024.PMID: 38694177 

Jana Lincoln

Civil Commitment Law with a Focus on Hospitalized Patients History and Practice in Kansas: Part I and Part II Masolak DD , Parker P , Lincoln J. Kans J Med 2023 Jan 18;16(1):21-24. doi: 10.17161/kjm.vol16.18707. eCollection 2023.PMID: 36703946

Phillip Martin

1. A Systematic Review and Meta-Analysis of the Utility of the Test of Memory Malingering in Pediatric Examinees. Clark HA, Martin PK, Okut H, Schroeder RW.Arch Clin Neuropsychol. 2020 Nov 19;35(8):1312-1322. doi: 10.1093/arclin/acaa075.PMID: 33047780

2. How Much Education and Training Do Residents Across Specialties Receive in Neuropsychology? Chowhan S, Martin PK, Macaluso M, Bowman C, Schroeder RW.Kans J Med. 2021 Aug 4;14(2):197-200. doi: 10.17161/kjm.vol1415200. eCollection 2021.PMID: 34367489 Free PMC article.

3. Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset. Wyman-Chick KA, O'Keefe LR, Weintraub D, Armstrong MJ, Rosenbloom M, Martin PK, Barclay TR, Barrett MJ.J Geriatr Psychiatry Neurol. 2022 Jul;35(4):527-534. doi: 10.1177/08919887211023586. Epub 2021 Jun 11.PMID: 34114509 Free PMC article.

4. Cross-validation of the Invalid Forgetting Frequency Index (IFFI) from the Test of Memory Malingering. Olsen DH, Schroeder RW, Martin PK.Arch Clin Neuropsychol. 2021 Apr 21;36(3):437-441. doi: 10.1093/arclin/acz064.PMID: 31792528

5. Base rates of invalidity when patients undergoing routine clinical evaluations have social security disability as an external incentive. Schroeder RW, Clark HA, Martin PK.Clin Neuropsychol. 2022 Oct;36(7):1902-1914. doi: 10.1080/13854046.2021.1895322. Epub 2021 Mar 11.PMID: 33706657

6. Feedback with patients who produce invalid testing: Professional values and reported practices. Martin PK, Schroeder RW.Clin Neuropsychol. 2021 Aug;35(6):1134-1153. doi: 10.1080/13854046.2020.1722243. Epub 2020 Feb 7.PMID: 32031048

7. Performance validity in the dementia clinic: Specificity of validity tests when used individually and in aggregate across levels of cognitive impairment severity. Martin PK, Schroeder RW, Olsen DH.Clin Neuropsychol. 2022 Jan;36(1):165-188. doi: 10.1080/13854046.2020.1778790. Epub 2020 Jun 17.PMID: 32552601

10. Base Rates of Invalid Test Performance Across Clinical Non-forensic Contexts and Settings. Martin PK, Schroeder RW.Arch Clin Neuropsychol. 2020 Aug 28;35(6):717-725. doi: 10.1093/arclin/acaa017.PMID: 32318712

11. Normal cognitive test scores cannot be interpreted as accurate measures of ability in the context of failed performance validity testing: A symptom- and detection-coached simulation study. Martinez KA, Sayers C, Hayes C, Martin PK, Clark CB, Schroeder RW.J Clin Exp Neuropsychol. 2021 Apr;43(3):301-309. doi: 10.1080/13803395.2021.1926435. Epub 2021 May 16.PMID: 33998369 Clinical Trial.

12. Neuropsychological Validity Assessment Beliefs and Practices: A Survey of North American Neuropsychologists and Validity Assessment Experts. Martin PK, Schroeder RW, Odland AP.Arch Clin Neuropsychol. 2025 Feb 18;40(2):201-223. doi: 10.1093/arclin/acae102.

Joshua Matyi

1. Impact of ictal spread on preoperative memory and language functions and postoperative seizure outcomes in drug-resistant epilepsy. Snehal I, Pulluru Y, Schissel M, Matyi J, Garlinghouse M, Ghonim HT, Phatak V, Taraschenko O.Epilepsy Behav. 2025 May 24;171:110497. doi: 10.1016/j.yebeh.2025.110497. Online ahead of print.PMID: 40414193

2. Lifetime estrogen exposure and cognition in late life: the Cache County Study. Matyi JM, Rattinger GB, Schwartz S, Buhusi M, Tschanz JT.Menopause. 2019 Dec;26(12):1366-1374. doi: 10.1097/GME.0000000000001405.PMID: 31613825 Free PMC article.

3. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study. Burhanullah MH, Tschanz JT, Peters ME, Leoutsakos JM, Matyi J, Lyketsos CG, Nowrangi MA, Rosenberg PB.Am J Geriatr Psychiatry. 2020 Jan;28(1):64-71. doi: 10.1016/j.jagp.2019.03.023. Epub 2019 May 23.PMID: 31186157 Free PMC article.

4. Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study. Rozum WJ, Cooley B, Vernon E, Matyi J, Tschanz JT.Int J Geriatr Psychiatry. 2019 Jul;34(7):1087-1094. doi: 10.1002/gps.5112. Epub 2019 Apr 25.PMID: 30945374 Free PMC article.

5. Caregiver-Care Recipient Relationship Closeness is Associated With Neuropsychiatric Symptoms in Dementia. Vernon EK, Cooley B, Rozum W, Rattinger GB, Behrens S, Matyi J, Fauth E, Lyketsos CG, Tschanz JT.Am J Geriatr Psychiatry. 2019 Apr;27(4):349-359. doi: 10.1016/j.jagp.2018.11.010. Epub 2018 Dec 1.PMID: 30616905 Free PMC article.

6. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care. Behrens S, Rattinger GB, Schwartz S, Matyi J, Sanders C, DeBerard MS, Lyketsos CG, Tschanz JT.Int Psychogeriatr. 2018 Oct;30(10):1499-1507. doi: 10.1017/S104161021800011X. Epub 2018 Mar 21.PMID: 29559029 Free PMC article.

7. Erratum to: "Sex Differences in Risk for Alzheimer's Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study". Matyi J, Tschanz JT, Rattinger GB, Sanders C, Vernon EK, Corcoran C, Kauwe JSK, Buhusi M.J Gerontol A Biol Sci Med Sci. 2018 Mar 2;73(3):311. doi: 10.1093/gerona/glx220.PMID: 29272340 Free PMC article. No abstract available.

8. Sex Differences in Risk for Alzheimer's Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study. Matyi J, Tschanz JT, Rattinger GB, Sanders C, Vernon EK, Corcoran C, Kauwe JSK, Buhusi M.J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1607-1613. doi: 10.1093/gerona/glx092.PMID: 28498887 Free PMC article.

Sheldon Preskorn

1. Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial. Preskorn SH, Zeller S, Citrome L, Finman J, Goldberg JF, Fava M, Kakar R, De Vivo M, Yocca FD, Risinger R.JAMA. 2022 Feb 22;327(8):727-736. doi: 10.1001/jama.2022.0799.PMID: 35191924 Free PMC article. Clinical Trial.

2. Thoughts on the Value of Case Series in the Literature: An Example Using the Article on Lurasidone Augmentation of Clozapine in Refractory Schizophrenia. Armstrong AG, Preskorn SH.J Clin Psychopharmacol. 2023 Mar-Apr 01;43(2):87-88. doi: 10.1097/JCP.0000000000001676.PMID: 36821468 No abstract available.

3. Reverse Engineering Drugs: Lorcaserin as an Example. Schwasinger-Schmidt T, Preskorn SH.Adv Neurobiol. 2023;30:195-206. doi: 10.1007/978-3-031-21054-9_8.PMID: 36928851

4. Contrave, Lybalvi, Auvelity, and Cobenfy: What Do They Have in Common? Preskorn SH.J Psychiatr Pract. 2025 Jul 1;31(4):214-216. doi: 10.1097/PRA.0000000000000863.PMID: 40679802 Review.

5. An Individual With 2 Distinct Nonpathologic Identities. Preskorn SH.J Psychiatr Pract. 2022 Jan 6;28(1):48-49. doi: 10.1097/PRA.0000000000000600.PMID: 34989344 

6. Consistency of the Antidepressant Effect of Intranasal Esketamine in Phase 3 Clinical Trials. Preskorn SH.J Psychiatr Pract. 2021 Mar 5;27(2):115-120. doi: 10.1097/PRA.0000000000000531.PMID: 33656817 Review.

7. How Loading Dose Strategies for Depot Paliperidone Can Go Wrong. Preskorn SH.J Psychiatr Pract. 2022 Mar 3;28(2):130-137. doi: 10.1097/PRA.0000000000000615.PMID: 35238824 Review.

8. Eight Clinical Cases and the Lessons They Taught. Preskorn SH.J Psychiatr Pract. 2023 Sep 1;29(5):373-377. doi: 10.1097/PRA.0000000000000736.PMID: 37678367

9. Life-threatening Rash Due to Lamotrigine and a Failure to Understand Its Pharmacology: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases. Preskorn SH, Masolak DD.J Psychiatr Pract. 2024 Jul 1;30(4):273-278. doi: 10.1097/PRA.0000000000000791.PMID: 39058526

10. Discovery of New Transmitter Systems and Hence New Drug Targets. Schwasinger-Schmidt T, Preskorn SH.Adv Neurobiol. 2023;30:181-193. doi: 10.1007/978-3-031-21054-9_7.PMID: 36928850

11. Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine. Preskorn SH, Rode R.J Psychiatr Pract. 2023 Nov 1;29(6):469-475. doi: 10.1097/PRA.0000000000000750.PMID: 37948171

12. Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions? Preskorn SH, Quadri S.J Psychiatr Pract. 2020 Nov;26(6):485-492. doi: 10.1097/PRA.0000000000000502.PMID: 33275385 Free PMC article.

13. Subtypes of Major Depressive Disorder Based on Pharmacological Responsiveness. Preskorn SH.J Psychiatr Pract. 2021 Nov 5;27(6):448-452. doi: 10.1097/PRA.0000000000000591.PMID: 34768267

14. The Essential Parallels Between Clinical Practice and the Scientific Method. Preskorn SH.J Psychiatr Pract. 2024 Jan 1;30(1):43-45. doi: 10.1097/PRA.0000000000000759.PMID: 38227726

15. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply. Preskorn SH, Risinger R, Kakar R.JAMA. 2022 Jul 12;328(2):214-215. doi: 10.1001/jama.2022.8349.PMID: 35819427 No abstract available.

16. COVID-19: Why Has the Mortality Rate Declined? Preskorn SH.J Psychiatr Pract. 2020 Sep;26(5):394-399. doi: 10.1097/PRA.0000000000000494.PMID: 32865940

17. Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial. Citrome L, Preskorn SH, Lauriello J, Krystal JH, Kakar R, Finman J, De Vivo M, Yocca FD, Risinger R, Rajachandran L.J Clin Psychiatry. 2022 Oct 3;83(6):22m14447. doi: 10.4088/JCP.22m14447.PMID: 36198061 Free article. Clinical Trial.

18. Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists-Daridorexant, Lemborexant, and Suvorexant: Part 1: Pharmacokinetic Profiles. Preskorn SH.J Psychiatr Pract. 2022 Nov 1;28(6):478-480. doi: 10.1097/PRA.0000000000000672.PMID: 36355586

19. Can the Publication of Case Series or Case Reports Lead to a Change in Clinical Practice? Preskorn SH, Armstrong AG.J Psychiatr Pract. 2023 Mar 1;29(2):137-141. doi: 10.1097/PRA.0000000000000701.PMID: 36928200

20. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development. Preskorn SH.Adv Neurobiol. 2023;30:1-18. doi: 10.1007/978-3-031-21054-9_1.PMID: 36928844

21 .Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists-Daridorexant, Lemborexant, and Suvorexant-Part 2. Principal Drug Metabolizing Enzyme, Drug-Drug Interactions, and Effects of Liver and Renal Impairment on Metabolism. Preskorn SH.J Psychiatr Pract. 2023 Jan 1;29(1):38-41. doi: 10.1097/PRA.0000000000000690.PMID: 36649550

22. Building a Comprehensive Biopsychosocial Database to Identify Underlying Causes of Suicide and Improve Suicide Prevention. Preskorn SH.J Psychiatr Pract. 2022 Sep 1;28(5):391-395. doi: 10.1097/PRA.0000000000000653.PMID: 36074108

23. Efficiency and Completeness in Outpatient Visits Using the Scientific Method and Analog Scales. Preskorn SH.J Psychiatr Pract. 2024 Nov 1;30(6):428-430. doi: 10.1097/PRA.0000000000000816.PMID: 39655969

24. Longitudinal Course of Adverse Events With Esketamine Nasal Spray: A Post Hoc Analysis of Pooled Data From Phase 3 Trials in Patients With Treatment-Resistant Depression. Williamson DJ, Gogate JP, Kern Sliwa JK, Manera LS, Preskorn SH, Winokur A, Starr HL, Daly EJ.J Clin Psychiatry. 2022 Sep 19;83(6):21m14318. doi: 10.4088/JCP.21m14318.PMID: 36149841 Free article.

25. Seven Mechanistically Different Classes of Medications Can Be Used to Treat Insomnia and Related Sleep Disorders. Preskorn SH.J Psychiatr Pract. 2023 May 1;29(3):227-234. doi: 10.1097/PRA.0000000000000709.PMID: 37200141

26. How an Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications. Preskorn SH.J Psychiatr Pract. 2022 May 1;28(3):227-233. doi: 10.1097/PRA.0000000000000634.PMID: 35511098

27. Charting and Handling Therapeutic Drug Monitoring Results: How they Differ From Most Laboratory Results. Preskorn SH.J Psychiatr Pract. 2021 Jul 28;27(4):283-287. doi: 10.1097/PRA.0000000000000567.PMID: 34398578

28. QTc, the Multitude of Ways It Is Calculated and Implications for Clinical Practice: A Case Example. Preskorn SH, Lochmann DB, Sohail Z.J Psychiatr Pract. 2021 Jan 21;27(1):43-47. doi: 10.1097/PRA.0000000000000526.PMID: 33438866

29. Charting and Handling Genetic Test Results: How They Differ From Most Laboratory Results. Preskorn SH.J Psychiatr Pract. 2021 May 5;27(3):194-198. doi: 10.1097/PRA.0000000000000543.PMID: 33939373

30. Fundamental Pharmacokinetic Concepts and Their Clinical Relevance: Clearance, Zero Versus First Order and Nonlinear Pharmacokinetics. Preskorn SH.J Psychiatr Pract. 2021 Sep 16;27(5):380-383. doi: 10.1097/PRA.0000000000000570.PMID: 34529604

31. From the Washington University (or Feighner) Psychiatric Diagnostic Criteria to DSM-III and Subsequent Versions: A Personal Perspective. Preskorn SH.J Psychiatr Pract. 2025 Mar 1;31(2):85-88. doi: 10.1097/PRA.0000000000000841.PMID: 40163573

32. A False-positive Diagnosis of a Lethal Serotonin Syndrome Based on Postmortem Whole-blood Levels of Sertraline: How Forensic Detective Work Uses Medical Knowledge and Clinical Pharmacology to Solve Cases. Preskorn SH, Masolak DD.J Psychiatr Pract. 2024 Sep 1;30(5):349-356. doi: 10.1097/PRA.0000000000000801.PMID: 39357016

33. How the Food and Drug Administration Drug Approval Process Relates to the Potential Approval of Intravenous Racemic Ketamine for Treatment-resistant Major Depression. Preskorn SH.J Psychiatr Pract. 2024 Mar 1;30(2):134-138. doi: 10.1097/PRA.0000000000000768.PMID: 38526401

34. How the Use of Generic Names for Drugs Can Help Patients Avoid Untoward Adverse Effects. Preskorn SH.J Psychiatr Pract. 2025 May 1;31(3):156-157. doi: 10.1097/PRA.0000000000000852.PMID: 40440671

35. Treatment of Agitation in Individuals With Bipolar Disorder or Schizophrenia: Lessons Learned for Clinical Psychiatry and Psychiatric Drug Development. Preskorn SH.J Psychiatr Pract. 2022 Jul 1;28(4):319-323. doi: 10.1097/PRA.0000000000000647.PMID: 35797688

36. An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression. Conway CR, Rush AJ, Gordon C, Preskorn SH, Sackeim HA, Aaronson ST, McIntyre RS, Lee YL, Shy O, Tran Q, Way J, Bunker MT.J Mood Anxiety Disord. 2025 Apr 14;10:100121. doi: 10.1016/j.xjmad.2025.100121. eCollection 2025 Jun.PMID: 40657595 Free PMC article.

37. Cerebral Anoxia in an 18-year-old Patient Being Treated for Major Depressive Disorder: How Forensic Detective Work Uses Medical Knowledge Including Clinical Pharmacology to Solve Cases. Preskorn SH, Masolak DD.J Psychiatr Pract. 2024 May 1;30(3):212-219. doi: 10.1097/PRA.0000000000000780.PMID: 38819245

38. How Quickly Multiple Medication Use Can Start: A Medication for Every Complaint on the First Visit Compromising the Ability to Determine Cause and Effect. Preskorn SH, Terry A.J Psychiatr Pract. 2025 Jan 1;31(1):24-26. doi: 10.1097/PRA.0000000000000835.PMID: 39836678

Christopher Siler

Polypharmacy in Older Adults: Case Study. Siler Ch, Fuller W, Whaley D, Keating J. S D Med. PMID: 36898199

Kamalakar Surineni

1. Valproate-Induced Thrombocytopenia: A Case Report. Surineni K, Wells E, Schrader N, Costa G, Ziegler M.Cureus. 2024 Jul 29;16(7):e65670. doi: 10.7759/cureus.65670. eCollection 2024 Jul.PMID: 39205734 Free PMC article.

2. A Case of Persistent Postictal and Inter-ictal Delirium. Le V, Wollard K, Lee RW, Surineni K.Kans J Med. 2023 Aug 24;16(2):214-217. doi: 10.17161/kjm.vol16.20116. eCollection 2023.PMID: 37791029 Free PMC article. No abstract available.

3. Use of Paliperidone Long-Acting Injections in Huntington's Disease. Surineni K, Le V, McKaughan K, Fotion N.J Clin Psychopharmacol. 2025 May-Jun 01;45(3):293-295. doi: 10.1097/JCP.0000000000001989. Epub 2025 Mar 25.PMID: 40127421 No abstract available.

4. The Emergence of Mania After Initiating Escitalopram for Anxiety Disorder. Surineni K, Armstrong A, Wallace S, Schrader N.Cureus. 2024 Jun 29;16(6):e63441. doi: 10.7759/cureus.63441. eCollection 2024 Jun.PMID: 39077268 Free PMC article.

5. A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure. Surineni K, Le V, Jones D.Cureus. 2024 Jun 19;16(6):e62692. doi: 10.7759/cureus.62692. eCollection 2024 Jun.PMID: 39036275 Free PMC article.

6. A Case of Olanzapine Resistance from Heavy Smoking and Clinical Considerations. Surineni K, Smith AL, Glein R, Schrader N.Kans J Med. 2025 Feb 17;18(1):21-22. doi: 10.17161/kjm.vol18.22846. eCollection 2025 Jan-Feb.PMID: 40093777 Free PMC article. No abstract available.

---

Resident publications

Shamil Abbasy

Heroin. Martin R. Huecker1, George A. Koutsothanasis2, Muhammad Shamil U. Abbasy , Jeanna Marraffa4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.2025 Aug 13.PMID: 28722906 

Marianna Berwerth Pereira

1. Managing a Complex Case of Bipolar Disorder in a Patient With Recurrent Hospitalizations. Okpaleke Amazu C, Nathwani K, Berwerth Pereira M, Rente Lavastida D, Parker JM.Cureus. 2024 Jul 10;16(7):e64271. doi: 10.7759/cureus.64271. eCollection 2024 Jul.PMID: 39130846 Free PMC article.

2. Mental Health of Medical Students Before and During COVID-19 Pandemic: a 3-Year Prospective Study. Pereira MB, Casagrande AV, Almeida BC, Neves BA, da Silva TCRP, Miskulin FPC, Perissotto T, Ribeiz SRI, Nunes PV.Med Sci Educ. 2022 Jun 29;32(4):873-881. doi: 10.1007/s40670-022-01580-3. eCollection 2022 Aug.PMID: 35789940 Free PMC article.

3. Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes. Perissotto T, Silva TCRPD, Miskulin FPC, Pereira MB, Neves BA, Almeida BC, Casagrande AV, Ribeiz SRI, Nunes PV.Clinics (Sao Paulo). 2021 Jul 5;76:e3007. doi: 10.6061/clinics/2021/e3007. eCollection 2021.PMID: 34231710 Free PMC article.

Gilmar Costa

Valproate-Induced Thrombocytopenia: A Case Report. Surineni K, Wells E, Schrader N, Costa G, Ziegler M.Cureus. 2024 Jul 29;16(7):e65670. doi: 10.7759/cureus.65670. eCollection 2024 Jul.PMID: 39205734 

Laura Dandridge

1. Adherence to laboratory testing in pediatric liver transplant recipients. Ryan JL, Dandridge LM, Fischer RT.Pediatr Transplant. 2021 May;25(3):e13899. doi: 10.1111/petr.13899. Epub 2020 Nov 1.PMID: 33131187

2. Conservative Management of Pneumatosis Intestinalis and Portal Venous Gas After Pediatric Liver Transplantation. Ryan JL, Dandridge LM, Andrews WS, Daniel JF, Fischer RT, Rivard DC, Wieser AB, Kane BJ, Hendrickson RJ.Transplant Proc. 2020 Apr;52(3):938-942. doi: 10.1016/j.transproceed.2020.01.010. Epub 2020 Feb 29.PMID: 32122661

Gregory Morrissey

Protocol for the systematic review and meta-analysis of factors associated with non-adherence to antidepressants in depressive disorders in those more than 18 years of age. Dhungana S, Rijal R, Regmi B, Bajracharya JS, Sharma S, Singh S, Karn N, Chapagai M.PLoS One. 2023 Feb 6;18(2):e0281366. doi: 10.1371/journal.pone.0281366. eCollection 2023.PMID: 36745620 

Saadiya Rehman

Left Ventricular Assist Device Support and Longitudinal Sleeve Gastrectomy Combined With Diet in Bridge to Heart Transplant. Ng M, Rodgers B, Rehman S, Nathan SS, Bajwa KS, Shah SK, Akkanti BH, Jumean MF, Kumar S, Dressel JL, Radovancevic R, Felinski MM, Kar B, Gregoric ID.Tex Heart Inst J. 2022 Jan 1;49(1):e207521. doi: 10.14503/THIJ-20-7521. PMID: 35201356

Alisha Sapkota

1. Clinical Mortality Review of COVID-19 Patients at Sukraraj Tropical and Infectious Disease Hospital, Nepal; A Retrospective Study. Bastola A, Shrestha S, Nepal R, Maharjan K, Shrestha B, Chalise BS, Thapa P, Balla P, Sapkota A, Shah P.Trop Med Infect Dis. 2021 Jul 19;6(3):137. doi: 10.3390/tropicalmed6030137.PMID: 34287389 

2. Depression, Anxiety, and Stress among First-year Medical Students in a Tertiary Care Hospital: A Descriptive Cross-sectional Study. Shah P, Sapkota A, Chhetri A.JNMA J Nepal Med Assoc. 2021 Apr 30;59(236):346-349. doi: 10.31729/jnma.6420.PMID: 34508520 

3. Untreated Depression During Pregnancy and Its Effect on Pregnancy Outcomes: A Systematic Review. Jahan N, Went TR, Sultan W, Sapkota A, Khurshid H, Qureshi IA, Alfonso M.Cureus. 2021 Aug 17;13(8):e17251. doi: 10.7759/cureus.17251. eCollection 2021 Aug.PMID: 34540477

4. Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review. Sapkota A, Khurshid H, Qureshi IA, Jahan N, Went TR, Sultan W, Alfonso M.Cureus. 2021 Aug 21;13(8):e17352. doi: 10.7759/cureus.17352. eCollection 2021 Aug.PMID: 34447651 

5. Psychoactive Substance Use among Second-Year and Third-Year Medical Students of a Medical College: A Descriptive Cross-sectional Study. Sapkota A, Silvanus V, Shah P, Gautam SC, Chhetri A.JNMA J Nepal Med Assoc. 2021 Jul 1;59(238):571-576. doi: 10.31729/jnma.6525.PMID: 34508402

6. Statins' Effect on Cognitive Outcome After Traumatic Brain Injury: A Systematic Review. Sultan W, Sapkota A, Khurshid H, Qureshi IA, Jahan N, Went TR, Dominic JL, Win M, Kannan A, Tara A, Ruo SW, Alfonso M.Cureus. 2021 Aug 6;13(8):e16953. doi: 10.7759/cureus.16953. eCollection 2021 Aug.PMID: 34405076 

Amy Terry

How Quickly Multiple Medication Use Can Start: A Medication for Every Complaint on the First Visit Compromising the Ability to Determine Cause and Effect. Preskorn SH, Terry A.J Psychiatr Pract. 2025 Jan 1;31(1):24-26. doi: 10.1097/PRA.0000000000000835.PMID: 39836678

---

Presentations

Psychiatry residents presented posters at KU School of Medicine-Wichita's annual Research Forum in April 2022:

• Jeffrey Bogard, M.D., with Javanthi Theegala, M.D., and faculty members Cassie Karlsson, M.D., and Rachna Kalia, M.D. Catatonia Associated with Cannabis Use: A Case Report.
• Danielle Jones, M.D., with Mary Johnson, M.D., Sandhya Mainali, M.D., and Rachna Kalia, M.D. Elder abuse in the setting of major neurocognitive disorders and delusions.
• Sandhya Mainali, M.D., with Seher Chowhan, M.D., and faculty member Susanna Ciccolari-Micaldi, M.D. Trauma and conduct disorder in a child and adolescent: a case report.
• Austin Armstrong, M.D., was second author with colleagues Schuknecht T, Keomany J, Okut H, Grainger D, Duncan FE. Fertility preservation knowledge and attitudes among medical students as future practitioners.

---

Post-doctoral trainees in neuropsychology were also active in research and scholarly activity. They presented posters at the Society for Pediatric Psychology Conference in 2022 in Phoenix:

• Lindsay Bratland, Ph.D., with faculty Dr. Netson-Amore. The intersection of gender and neurodiversity: A case study of a TGNC youth on the autism spectrum.
• Joshua Sensenbaugh, Ph.D., with Dr Netson-Amore. Jeavon’s Syndrome in a fourteen-year-old girl: The role of advocating for uncommon conditions.

---

Faculty in the department are active nationally, regionally and locally in research, scholarly activity and the dissemination of knowledge and expertise: 

• Susanna Ciccolari-Micaldi, M.D., presented Grand Rounds to the department on her area of expertise, Irritability in Youth.
• Dr. Ciccolari-Micaldi has provided scholarly mentorship for residents, including on a published poster. She reviewed for American Family Physician.
• Susanna Ciccolari-Micaldi, M.D. reviewed for American Family Physician.
• Cassie Karlsson, M.D., was a member of a panel presentation at the American Academy of Child and Adolescent Psychiatry Annual Conference with colleagues in October 2021, The Many Faces of Pediatric Catatonia: Beyond Waxy Flexibility and Echo Phenomena. Clinical Perspectives.
• Dr. Karlsson co-presented posters with faculty colleagues, Drs. Schroeder, Martin and others, at the American Neuropsychiatric Association Annual Meeting in March 2022, An Examination of the relationships between neuropsychological functioning and instrumental activities of daily living in patients with neurocognitive disorders and Reported benefits of a personalized music intervention for neuropsychiatric symptoms associated with dementia.
• Nicole Klaus, Ph.D., has provided multiple presentations on topics related to suicide prevention; they included a series of Webinars for the KU Area Health Education Center in September 2021 and presentations to the Kansas Department of Health and Environment, the Special Committee on Kansas Mental Health Modernization and Reform, and the Midwest Provider Clinical Conference in June 2022.
• Dr. Klaus and colleague Kelli Netson-Amore, Ph.D., provided presentations on COVID-19’s impact on youth mental health, including to the Sedgwick County Superintendents’ Forum and to the department’s Grand Rounds.
• Kelli Netson-Amore, Ph.D., was co-author of an article in the Journal of Clinical Oncology; Foster R et al, Cognitive Impairment in Survivors of Pediatric Extracranial Solid Tumors and Lymphomas. Journal of Clinical Oncology 39:16, 1727-1740.
• With colleague Melissa Hopper, Ph.D., Dr. Netson presented to the Kansas chapter of the American Academy of Pediatrics on topics related to COVID and mental health. Dr. Netson mentored trainees in scholarly activities that have led to presentations this year.
• Janka Lincoln, M.D., was the Kansas Psychiatric Society’s representative to the American Psychiatric Association in 2021-22 and has been elected as council member for the upcoming year.
• Shannon Loeck, M.D., was the keynote speaker for KU Medical Center's National Physician Suicide Awareness Day in 2021.
• Sheldon Preskorn, M.D., continued to publish extensively on topics related to neuropsychopharmacology throughout 2021 and 2022.
• Dr. Preskorn authored multiple articles in the Journal of Psychiatric Practice – QTc, the Multitude of Ways It Is Calculated and Implications for Clinical Practice: A Case Example 27((1)), 43-47; Consistency of the Antidepressant Effect of Intranasal Esketamine in Phase 3 Clinical Trials. 27(2), 115-120; Charting and Handling Genetic Test Results: How They Differ From Most Laboratory Results 27(3), 194-198; Charting and Handling Therapeutic Drug Monitoring Results: How they Differ From Most Laboratory Results 27(4), 283-28; Fundamental Pharmacokinetic Concepts and Their Clinical Relevance: Clearance, Zero Versus First Order and Nonlinear Pharmacokinetics; 27(5), 380-383; Subtypes of Major Depressive Disorder Based on Pharmacological Responsiveness 27(6), 448-452; An Individual with 2 Distinct Nonpathologic Identities 28(1):48-49; How Loading Dose Strategies for Depot Paliperidone Can Go Wrong 28(2):130-137; How An Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications 28(3):227-233.
• In 2022, Dr. Preskorn was lead author of a multiauthor publication in the Journal of the American Medical Association about a new medication approved for the treatment of acute  agitation in schizophrenia and bipolar illness, BXCL501 Achieves Rapid Control of Agitation in Patients with Bipolar Disorder 327(8):727-736. In the first three months after publication, the article had more than 21,000 views. Further publications about this medication, dexmedetomidine, are expected. 
• Dr. Preskorn was named Educator of the Year by Psychiatric Times ^TM in 2021. He presented the Educator of the Year Lecture at the Annual Psychiatric Times World ^tm CME conference in fall 2021, as well as a lecture on State-of-the-Art Treatment in Major Depressive Disorder.
• Dr. Preskorn presented a plenary lecture at the Boston Society in October 2021, Why are Patients with COVID-19 at Risk for DDI, and What Can be Done to Minimize the Adverse     Outcomes. He reviews for multiple psychiatric journals.
• Ryan Schroeder, Ph.D., and Philip Martin, Ph.D., neuropsychologists, have contributed extensively to the literature on validity assessment in neuropsychological practice. They jointly edited a textbook on the topic published in 2021 for Guilford Press Validity assessment in clinical neuropsychological practice: Evaluating and Managing Noncredible Performance and together and with colleagues authored multiple chapters in the text. In addition, Schroeder has led three national and one regional workshop, and published two peer-reviewed articles, 11 abstracts/presentations and 12 book chapters. Dr. Martin has led one regional workshop and published five peer-reviewed articles, seven abstracts/poster presentations and 11 book chapters.
• Dr. Martin is a joint author of two chapters in Assessment of Feigned Cognitive Impairment edited by Kyle Boone, Comparison of Forced Choice PVTs, and Language Tests as PVTs.
• Dr. Martin presented an invited seminar with colleagues to the American Academy of Clinical Neuropsychology (AACN) in 2022 "But I Tried My Best!: Providing Feedback After Invalid Presentations in Adult and Pediatric Clinical Neuropsychological Evaluations." He also presented to the Alzheimer’s Association Midwest region and to the internship training program at Cordell and Associates in Dayton OH.
• Cheryl Wehler, M.D., authored Panic Disorder, a book chapter in Conn’s Current Therapy Eds. Kellerman K and Rakel D in 2021 and 2022.

---

Jointly with the KU School of Medicine-Wichita Department of Pediatrics, the Department of Psychiatry & Behavioral Sciences continues to provide services through KSKidsMAP, the Pediatric Mental Healthcare Access Program for Kansas, funded by the Health Research and Services Administration through the Kansas Department of Health and Environment (KDHE).

• The grant supports Susanna Ciccolari-Micaldi M.D., Cassie Karlsson, M.D., and Nicole Klaus, Ph.D., from our department to provide case consultations and clinical resources to primary care physicians and other clinicians, including a series of toolkits published on the KDHE website. We work closely with department of pediatrics faculty, especially Kari Harris, M.D., on the clinical aspects of the program. The evaluation is led by Cari Schmidt, Ph.D., from the Department of Pediatrics. Department members have given multiple presentations related to the work of KSKidsMAP.
• Our PMHCA team has a particular focus on physician and clinician wellness; presentations included Klaus, who joined Dr. Harris and Amanda Aguila-Gonzalez, MPH, in October 2021 to present at the National Academies of Science, Engineering and Medicine Forum on Children's Wellbeing Fall Workshop. In April 2022, Dr. Klaus joined Dr. Harris to present at the KDHE Public Health Department Staff Retreat, on Tending to our Mental Health.
• In May 2022, led by Nicole Klaus, Ph.D., the department received a grant from the Kansas Department of Aging and Disability Services to provide after-school programming in the Haysville School District. The BREATHE program (Building Resilience and Healthy Relationships in Youth with ADHD) is modeled after an evidence-based intensive summer treatment program for ADHD.